Sort
65,743 grants matching “single cell sequencing”
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,549,996Steven A Yukl · University Of California, San Francisco · P01 · FY2023 · AI
Genetics Core
$1,548,987Christopher C Goodnow · Scripps Research Institute, The · U19 · FY2012 · AI
Cell Interactions in Three Dimensional Tissue Culture
$1,548,559Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
NEI Genetic Engineering Core
$1,548,127Lijin Dong · National Eye Institute · ZIC · FY2017 · EY
Yale/NIDA Neuroproteomics Center
$1,548,122Kenneth Robert Williams · Yale University · P30 · FY2017 · DA
Statistical genetics of aging-related genomic and phenotypic change
$1,547,874Jun Ding · National Institute On Aging · ZIA · FY2020 · AG
Identifying cell-type specific genetic control of T1D risk variants in TEDDY
$1,547,165Suna Onengut · University Of Virginia · R01 · FY2025 · DK
NIEHS Gene Editing and Mouse Model (GEMM) Core Annual Report
$1,546,971Manas Ray · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
Phenotype Heterogeneity and Dynamics in SCLC
$1,546,936Vito Quaranta · Vanderbilt University · U54 · FY2022 · CA
Animal Model and Genotyping Core Support Facility
$1,546,907Wendy Du Bois · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Electronic Sequencing in Nanopores
$1,546,885Jene A Golovchenko · Harvard University · R01 · FY2010 · HG
Mechanisms of Initiation and Persistence of Allergic Asthma
$1,546,847Dean Sheppard · University Of California, San Francisco · U19 · FY2011 · AI
Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
$1,546,361Aileen Chang · George Washington University · U01 · FY2024 · AR
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
$1,545,877Martin R. Pollak · Beth Israel Deaconess Medical Center · RC2 · FY2020 · DK
Genome Instability in Cancer Development
$1,545,815Kyungjae Myung · National Human Genome Research Institute · ZIA · FY2010 · HG
Single cell isoform expression across mouse brain regions and development
$1,545,372Hagen Ulrich Tilgner · Weill Medical Coll Of Cornell Univ · RF1 · FY2019 · MH
Initiation of DNA Replication in Mammalian Cells
$1,545,289Mirit Aladjem · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
$1,545,130Russell E Ware · Cincinnati Childrens Hosp Med Ctr · U01 · FY2022 · HL
Clonal analysis of in vivo hematopoiesis
$1,543,957Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
$1,543,917James M Olson · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
$1,542,693Paul Stephen Keim · Northern Arizona University · U19 · FY2023 · AI
Single Cell Transcript counting of Stem Cell Differentiation and Reprogramming
$1,542,435Alexander Van Oudenaarden · Massachusetts Institute Of Technology · U54 · FY2012 · CA
Uncovering associations of variant infection with COVID-19 disease severity in children
$1,541,111Charles Yen Chiu · University Of California, San Francisco · R61 · FY2022 · HD
Development of new antibody-based cancer therapies
$1,541,067Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
$1,540,837Qijing Li · Duke University · R33 · FY2017 · CA